The Effect of Changing Technique, Dose, and PTV Margin on Therapeutic Ratio During Prostate Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 4, 2008, Pages 1057-1064

  Huang, Shao Hui ^a,b   Catton, Charles ^a,b   Jezioranski, John ^a,b   Bayley, Andrew ^a,b   Rose, Stuart ^a   Rosewall, Tara ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Conformal radiotherapy; Dose escalation; Image guidance; Prostate cancer; PTV margin

Indexed keywords

CONFORMAL RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY (IMRP); LOCALIZED PROSTATE CANCER; PLANNING PARAMETERS; PLANNING SYSTEMS; PLANNING TARGET VOLUME (PTV); PROSTATE RADIOTHERAPY; REPRESENTATIVE SAMPLE;

ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PARAMETER; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; RADIATION DOSE; RADIOBIOLOGY; RANDOM SAMPLE; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING;

ADULT; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 45449099911     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.11.055     Document Type: Article

References (55)

1. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson Phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
2. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1239
3. Sathya J.R., Davis I.R., Julian J.A., et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 23 (2005) 1192-1199
4. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized Phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
5. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1314-1321
6. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55 (2000) 241-249
7. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial. Lancet 353 (1999) 267-272
8. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. [see comment]. J Urol 166 (2001) 876-881 [erratum appears in J Urol 2001;166:1839]
9. Dearnaley D.P., Hall E., Lawrence D., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 92 (2005) 488-498
10. Brabbins D., Martinez A., Yan D., et al. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity. Int J Radiat Oncol Biol Phys 61 (2005) 400-408
11. Nichol A., Chung P., Lockwood G., et al. A Phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy. Radiother Oncol 76 (2005) 11-17
12. Skala M., Rosewall T., Dawson L., et al. Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 690-698
13. Wang X.H., Mohan R., Jackson A., et al. Optimization of intensity-modulated 3D conformal treatment plans based on biological indices. Radiother Oncol 37 (1995) 140-152
14. Ling C.C., Burman C., Chui C.S., et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 35 (1996) 721-730
15. Oh C.E., Antes K., Darby M., et al. Comparison of 2D conventional, 3D conformal, and intensity-modulated treatment planning techniques for patients with prostate cancer with regard to target-dose homogeneity and dose to critical, uninvolved structures. Med Dosim 24 (1999) 255-263
16. Fiorino C., Broggi S., Corletto D., et al. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams. Radiother Oncol 55 (2000) 49-58
17. Reinstein L.E., Wang X.H., Burman C.M., et al. A feasibility study of automated inverse treatment planning for cancer of the prostate. Int J Radiat Oncol Biol Phys 40 (1998) 207-214
18. Martinez A.A., Yan D., Lockman D., et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1226-1234
19. Luxton G., Hancock S.L., and Boyer A.L. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 59 (2004) 267-284
20. Vlachaki M.T., Teslow T.N., Amosson C., et al. IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization. Med Dosim 30 (2005) 69-75
21. De Meerleer G.O., Vakaet L.A., De Gersem W.R., et al. Radiotherapy of prostate cancer with or without intensity modulated beams: A planning comparison. Int J Radiat Oncol Biol Phys 47 (2000) 639-648
22. Lee C.T., Dong L., Ahamad A.W., et al. Comparison of treatment volumes and techniques in prostate cancer radiation therapy. Am J Clin Oncol 28 (2005) 618-625
23. Song W.Y., Schaly B., Bauman G., et al. Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: A radiobiologic analysis. Int J Radiat Oncol Biol Phys 64 (2006) 289-300
24. Wu Q., Ivaldi G., Liang J., et al. Geometric and dosimetric evaluations of an online image-guidance strategy for 3D-CRT of prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1596-1609
25. Ghilezan M., Yan D., Liang J., et al. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys 60 (2004) 1602-1610
26. Chung P.W., Haycocks T., Brown T., et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 60 (2004) 329-334
27. Zhang M., Moiseenko V., Liu M., et al. Internal fiducial markers can assist dose escalation in treatment of prostate cancer: Result of organ motion simulations. Phys Med Biol 51 (2006) 269-285
28. International Commission on Radiation Units and Measurements (ICRU). ICRU-62. Prescribing, Recording and Reporting Photon Beam Therapy (supplement to ICRU Report 50): Washington, DC: ICRU; 1999.
29. Vargas C., Martinez A., Kestin L.L., et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1297-1308
30. Cheung M.R., Tucker S.L., Dong L., et al. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67 (2007) 1059-1065
31. Sanchez-Nieto B., and Nahum A.E. BIOPLAN: Software for the biological evaluation of radiotherapy treatment plans. Med Dosim 25 (2000) 71-76
32. Tucker S.L., Dong L., Cheung R., et al. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 1589-1601
33. Hornby C.J., Ackerly T., See A., et al. Exploring the effect of marked normal structure volume on normal tissue complication probability. Med Dosim 28 (2003) 223-227
34. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
35. Wang J.Z., Li X.A., Yu C.X., et al. The low alpha/beta ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us?. Int J Radiat Oncol Biol Phys 57 (2003) 1101-1108
36. Wang J.Z., Guerrero M., and Li X.A. How low is the alpha/beta ratio for prostate cancer?. Int J Radiat Oncol Biol Phys 55 (2003) 194-203
37. Fowler J.F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44 (2005) 265-276
38. Fowler J.F., Ritter M.A., Chappell R.J., et al. What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys 56 (2003) 1093-1104
39. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
40. Levegrun S., Jackson A., Zelefsky M.J., et al. Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. Int J Radiat Oncol Biol Phys 47 (2000) 1245-1260
41. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
42. Altman D. Practical statistics for medical research. 8th ed. Vol. 1 (1997), Chapman & Hall/CRC, London
43. Wambersie A., DeLuca P., and Whitmore G. Preface. J ICRU 4 (2004) 11-13
44. Haycocks T., Mui J., Alasti H., et al. Dose volume histogram analysis for organs at risk when using 6 external beam techniques for radical prostate irradiation. J Radiother Pract 2 (2000) 17-25
45. Amer A.M., Mott J., Mackay R.I., et al. Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 56 (2003) 199-207
46. Brenner D.J. Toward optimal external-beam fractionation for prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 315-316
47. Amer A.M., Mackay R.I., Roberts S.A., et al. The required number of treatment imaging days for an effective off-line correction of systematic errors in conformal radiotherapy of prostate cancer-a radiobiological analysis. Radiother Oncol 61 (2001) 143-150
48. Neal A.J., Oldham M., and Dearnaley D.P. Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities. Radiother Oncol 37 (1995) 29-34
49. Tucker S.L., Cheung R., Dong L., et al. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 353-365
50. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1-7
51. Nutting C.M., Corbishley C.M., Sanchez-Nieto B., et al. Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol 75 (2002) 151-161
52. Wigg D. Applied radiobiology and bioeffect planning (2001), Medical Physics Publishing, Madison, WI
53. Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52 (2002) 6-13
54. Vargas C., Yan D., Kestin L.L., et al. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: Use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys 63 (2005) 141-149
55. Sanchez-Nieto B., Nahum A.E., and Dearnaley D.P. Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data. Int J Radiat Oncol Biol Phys 49 (2001) 487-499